When Age Changes the Rules of Cancer Biology
Aging is the strongest risk factor for cancer, yet for much of my scientific training it existed as a background statistic rather than a biological… Read More »When Age Changes the Rules of Cancer Biology
Cancer
Embrace the Unpredictability in Life
It was 11 p.m. when my phone suddenly rang as I finished a late imaging session. It was a call from my mother. Given the… Read More »Embrace the Unpredictability in Life
Oncology: Offering Hope to Patients in Need
Much of the general public believes oncology is a “sad” field. Amol Narang, and many other practicing oncologists, disagree. Learn about his inspiring profession and why he would choose to be an oncologist time and time again.
Foghorn Therapeutics Breaks New Ground in Cancer Epigenetics
Epigenetic drugs are an emerging class of cancer therapeutics. In this article, Ph.D. candidate Roshan Chikarmane introduces Foghorn Therapeutics, its co-founder, Cigall Kadoch, and the science behind their drug development program.
Next Generation Cancer Diagnostics Revolutionize Patient Care
Next generation cancer diagnostics are poised to change the way that cancer is detected and treated. Ph.D. candidate Roshan Chikarmane shares his perspectives on the teams and technologies that are leading the charge.
Cancer in the Time of Coronavirus
Health care has pivoted in response to COVID-19, but how have these changes affected cancer patients? A student shares her perspective on having a parent with cancer during the pandemic.
Chasing Cancer: How the COVID-19 Pandemic Affects Cancer Outcomes
Pulitzer Prize-winning author and oncologist Siddhartha Mukherjee along with former executive vice president of the American Cancer Society and Hopkins oncologist Otis Brawley spoke with the Washington Post about how COVID-19 affects cancer outcomes.
The Longrifles Seminar: A Legacy of Collaboration
The Longrifles Cancer Seminar series, founded by Don Coffey, remains a hub of collaborative brainstorming for the Brady Urological Institute.
Cancer Diagnosis — It’s in Your Blood
The benefits of detecting and treating cancer at early developmental stages have long been observed by clinical oncologists. Colonoscopies as well as other methods for… Read More »Cancer Diagnosis — It’s in Your Blood
Cancer and the Mutation Paradox
It has long been known — thanks largely to work by Johns Hopkins’ own Bert Vogelstein — that cancer is a disease generally caused by… Read More »Cancer and the Mutation Paradox